for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Spinnaker Opportunities PLC

SOP.L

Latest Trade

4.65GBp

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

4.20

 - 

4.99

As of on the London Stock Exchange (LON) ∙ Minimum 15 minute delay

Pricing

Previous Close
4.65
Open
--
Volume
--
3M AVG Volume
0.00
Today's High
--
Today's Low
--
52 Week High
4.99
52 Week Low
4.20
Shares Out (MIL)
29.40
Market Cap (MIL)
1.37
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Spinnaker Opportunities Chairman Says Kanabo Deal Value Sits Comfortably Within 5-30 Mln Stg Range

Spinnaker Opportunities Says Agreed To Acquire Kanabo

Spinnaker Opportunities To Acquire Issued Share Capital Of Kanabo Research

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Spinnaker Opportunities PLC

Spinnaker Opportunities Plc is a United Kingdom-based company formed for the purpose of acquiring a target company or business or asset with operations in the energy or industrial sectors. Its efforts in identifying a prospective target company or acquisition in the energy or industrial sectors is not be limited to a specific geographical region, stage of development from exploration through to production or to a particular commodity. The Company has no operations.

Contact Info

59-60 Russell Square

http://www.spinnakeropportunities.uk/

Executive Leadership

Andrew John Gowdy Morrison

Chairman of the Board

David Anthony Little

Secretary

Anthony James Harpur

Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
1.55
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-22.55
Return on Equity (TTM)
-22.07

Latest News

Latest News

Israeli cannabis firm Kanabo to be bought by UK's Spinnaker

Kanabo Research has agreed to be bought by cash shell Spinnaker Opportunities <SOP.L> in what could lead to the first listing of a cannabis company on London's main stock market and help the Israeli firm raise cash for clinical trials and newer products.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up